Practical and methodological aspects of managing a registry to assess the quality of health care for patients with heart failure. A systematic review
https://doi.org/10.15829/1560-4071-2025-6345
EDN: UFGGKN
Abstract
The aim was to determine the key requirements for a heart failure (HF) registry designed to monitor the implementation of clinical guidelines in everyday practice. A systematic literature review was conducted using the PRISMA methodology to identify multicenter HF registries. The PubMed and eLibrary databases were used. The search depth was 2015-2025. For the final analysis, 46 sources were selected, which presented data from 27 multicenter registries (19 foreign and 8 Russian). An assessment of the registers’ compliance with the main quality criteria was carried out according to guidelines of Martsevich SYu, et al., 2023. Registry designed for routine monitoring of the implementation of clinical guidelines should be: 1) continuously operational; 2) accessible 24/7 in real-time; 3) results are presented in terms of approved quality criteria; 4) achieved results compared to the average result of the reference group; 5) the organizational structure of the registry and algorithms for calculating indicators are universal and publicly available; 6) the organizational structure and calculation algorithms are based on quality measures presented in clinical guidelines but adapted (selected and detailed) for the purposes of maintaining the registry. It should also meet the basic quality criteria for a register as a tool of evidence-based medicine.
About the Authors
O. M. PosnenkovaRussian Federation
Saratov
T. M. Bogdanova
Russian Federation
Saratov
A. S. Fedonnikov
Russian Federation
Saratov
References
1. Galyavich AS, Tereshchenko SN, Uskach TM, et al. 2024 Clinical practice guidelines for Chronic heart failure. Russian Journal of Cardiology. 2024;29(11):6162. (In Russ.) Гdoi:10.15829/1560-4071-2024-6162. EDN: WKIDLJ.
2. Dawson PL, Biswas S, Lefkovits J, et al. Characteristics and quality of national cardiac registries: A systematic review. Circ Cardiovasc Qual Outcomes. 2021;14:e007963. doi:10.1161/CIRCOUTCOMES.121.007963.
3. Gliklich RE, Leavy MB, Dreyer NA (sr eds). Registries for Evaluating Patient Outcomes: A User’s Guide. 4th ed. Rockville, MD: Agency for Healthcare Research and Quality; 2020: 415 p.
4. Martsevich SYu, Kutishenko NP, Lukina YuV, et al. Observational studies and registers. Their quality and role in modern evidence-based medicine. Cardiovascular Therapy and Prevention. 2021;20(2):2786. (In Russ.) doi:10.15829/1728-8800-2021-2786.
5. Martsevich SYu, Kutishenko NP, Lukina YuV, et al. Medical registries. Role in evidence-based medicine. Recommendations for creation. Guidelines. М.: RSPCND, "Siliceya-Polygraph" LLC, 2023: 44 p. (In Russ.) doi:10.15829/ROPNIZ-m1-2023. EDN: OCKJVC.
6. Rao VN, Mentz RJ, Coniglio AC, et al. Neighborhood socioeconomic disadvantage and hospitalized heart failure outcomes in the American Heart Association Get With The Guidelines-Heart Failure Registry. Circ Heart Fail. 2022;15:e009353. doi:10.1161/CIRCHEARTFAILURE.121.009353.
7. Tang AB, Lewsey SC, Yancy CW, et al. Get With the Guidelines-Heart Failure: Twenty years in review, lessons learned, and the road ahead. Circ Heart Fail. 2025;18:e012936. doi:10.1161/CIRCHEARTFAILURE.125.012936.
8. Fleming LM, Jones P, Chan PS, et al. Relationship of provider and practice volume to performance measure adherence for coronary artery disease, heart failure, and atrial fibrillation: results from the national cardiovascular data registry. Circ Cardiovasc Qual Outcomes. 2016;9:48-54. doi:10.1161/CIRCOUTCOMES.115.002159.
9. Gómez-Mesa JE, Gutiérrez-Posso JM, Escalante-Forero M, et al. American registry of ambulatory and acute decompensated heart failure (AMERICCAASS registry): Rationale and design. ESC Heart Failure. 2024;11:3805-13. doi:10.1002/ehf2.14965.
10. DeVore AD, Thomas L, Albert NM, et al. Change the management of patients with heart failure: Rationale and design of the CHAMP-HF registry. American Heart Journal. 2017;189:177-83. doi:10.1016/j.ahj.2017.04.010.
11. Nakano K, Nochioka K, Yasuda S, et al. Machine learning approach to stratify complex heterogeneity of chronic heart failure: A report from the CHART-2 study. ESC Heart Failure. 2023;10:1597-604. doi:10.1002/ehf2.14288.
12. Teng TK, Tromp J, Tay WT, et al. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study. Lancet Glob Health. 2018;6(9):e1008-e1018. doi:10.1016/S2214-109X(18)30306-1.
13. MacDonald MR, Tay WT, Teng TK, et al. Regional Variation of Mortality in Heart Failure With Reduced and Preserved Ejection Fraction Across Asia: Outcomes in the ASIAN-HF Registry. J Am Heart Assoc. 2020;9(1):e012199. doi:10.1161/JAHA.119.012199.
14. Li L, Liu R, Jiang C, et al. Assessing the evidence-practice gap for heart failure in China: the Heart Failure Registry of Patient Outcomes (HERO) study design and baseline characteristics. European Journal of Heart Failure. 2020;22:646-60. doi:10.1002/ejhf.1630.
15. Wang H, Li Y, Chai K, et al. Mortality in patients admitted to hospital with heart failure in China: a nationwide Cardiovascular Association Database — Heart Failure Centre Registry cohort study. Lancet Glob Health. 2024;12(4):e611-e622. doi:10.1016/S2214-109X(23)00605-8.
16. Martínez-Carreño E, Eduardo Echeverría L, Rivera-Toquica A, et al. Clinical Characteristics and Outcomes of Patients with Heart Failure of Hypertensive Etiology: Analysis of Colombian Heart Failure Registry (RECOLFACA). Kidney Blood Press Res. 2024;49(1):165-72. doi:10.1159/000535705.
17. Sandoval-Luna JA, Rivera-Toquica A, Saldarriaga C, et al. Characteristics, Treatment, and Prognosis of Heart Failure Patients with Chronic Obstructive Pulmonary Disease in the Colombian Heart Failure Registry (RECOLFACA). J. Cardiovasc. Dev. Dis. 2024;11:265. doi:10.3390/jcdd11090265.
18. Harikrishnan S, Sanjay G, Agarwal AZ, et al. One-year mortality outcomes and hospital readmissions of patients admitted with acute heart failure: Data from the Trivandrum Heart Failure Registry in Kerala, India. Am Heart J. 2017;189:193-9. doi:10.1016/j.ahj.2017.03.019.
19. Joseph P, Dokainish H, McCready T, et al. A multinational registry to study the characteristics and outcomes of heart failure patients: The global congestive heart failure (G-CHF) registry. Am Heart J. 2020;227:56-63. doi:10.1016/j.ahj.2020.06.002.
20. Walli-Attaei M, Joseph P, Johansson I, et al. Characteristics, management, and outcomes in women and men with congestive heart failure in 40 countries at different economic levels: an analysis from the Global Congestive Heart Failure (G-CHF) registry. Lancet Glob Health. 2024;12:e396-405. doi:10.1016/S2214-109X(23)00557-0.
21. Chioncel O, Mebazaa A, Harjola VP. Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long-Term Registry. Eur J Heart Fail. 2017;19:1242-54. doi:10.1002/ejhf.890.
22. Chioncel O, Lainscak M, Seferovic PM, et al. Epidemiology and one-year outcomes in patients with chronic heart failure and pre-served, mid-range and reduced ejection fraction: ananalysis of the ESC Heart Failure Long-Term Registry. Eur J Heart Fail. 2017;(12):1574-85. doi:10.1002/ejhf.813.
23. Lund LH, Crespo-Leiro MG, Laroche C, et al. Rationale and design of the ESC Heart Failure III Registry — Implementation and discovery. European Journal of Heart Failure. 2023;25:2316-30. doi:10.1002/ejhf.3087.
24. Lund LH, Crespo-Leiro MG, Laroche C, et al. Heart failure in Europe: Guideline-directed medical therapy use and decision making in chronic and acute, pre-existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction — the ESC EORP Heart Failure III Registry. European Journal of Heart Failure. 2024;26:2487-501. doi:10.1002/ejhf.3445.
25. Komajda M, Cowie MR, Tavazzi L, et al. Physicians’ guideline adherence is associated with better prognosis in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry. European Journal of Heart Failure. 2017;19,1414-23. doi:10.1002/ejhf.887.
26. Tereshchenko SN, Zhirov IV, Petrukhina AA. Clinical and demographic characteristics of an outpatient Russian population with chronic heart failure at the time of enrollment in the QUALIFY registry for evaluating consistency with clinical guidelines on drug therapy. Kardiologiia. 2017;57(S2):324-30. (In Russ.)doi:10.18087/cardio.2363.
27. Lund LH, Carrero JJ, Farahmand B, et al. Association between enrolment in a heart failure quality registry and subsequent mortality — a nationwide cohort study. Eur J Heart Fail. 2017;19(9):1107-16. doi:10.1002/ejhf.762.
28. Savarese G, Hage C, Benson L, et al. Eligibility for sacubitril/valsartan in heart failure across the ejection fraction spectrum: real-world data from the Swedish Heart Failure Registry. J Intern Med. 2021;289:369-84. doi:10.1111/joim.13165.
29. Batra G, Aktaa S, Benson L, et al. Association between heart failure quality of care and mortality: a population-based cohort study using nationwide registries. European Journal of Heart Failure. 2022;24:2066-77. doi:10.1002/ejhf.2725.
30. Aktaa S, Polovina M, Rosano G, et al. European Society of Cardiology quality indicators for the care and outcomes of adults with heart failure. Developed by the Working Group for Heart Failure Quality Indicators in collaboration with the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure. 2022;24:132-42. doi:10.1002/ejhf.2371.
31. Ødegaard KM, Lirhus SS, Melberg HO, et al. A nationwide registry study on heart failure in Norway from 2008 to 2018: variations in lookback period affect incidence estimates. BMC Cardiovascular Disorders. 2022;22:88. doi:10.1186/s12872-022-02522-y.
32. Trullàs JC, Pérez-Calvo JI, Conde-Martel A, et al. Epidemiology of heart failure with preserved ejection fraction: Results from the RICA Registry. Med Clin (Barc). 2021;157(1):1-9. doi:10.1016/j.medcli.2020.05.059.
33. Guisado-Espartero ME, Salamanca-Bautista P, Aramburu-Bodas Ó, et al. Causes of death in hospitalized patients in internal medicine departments with heart failure according to ejection fraction. RICA registry. Med Clin (Barc). 2022;158(1):13-9. doi:10.1016/j.medcli.2020.10.022.
34. Trullàs JC, Moreno-García MC, Mittelbrunn-Alquézar V, et al. The RICA-2 registry: design and baseline characteristics of the first 1,000 patients. Rev Clin Esp (Barc). 2024;224(8):522-33. doi:10.1016/j.rceng.2024.07.008.
35. Pagnesi M, Lombardi CM, Chiarito M. Prognostic impact of the updated 2018 HFA-ESC definition of advanced heart failure: results from the HELP-HF registry. European Journal of Heart Failure. 2022;24:1493-503. doi:10.1002/ejhf.2561.
36. Tomasoni D, Pagnesi M, Colombo G, et al. Guideline-directed medical therapy in severe heart failure with reduced ejection fraction: An analysis from the HELP-HF registry. European Journal of Heart Failure. 2024;26:327-37. doi:10.1002/ejhf.3081.
37. Táborský M, Skála T, Lazárová M, et al. Trends in the treatment and survival of heart failure patients: a nationwide population-based study in the Czech Republic. ESC Heart Failure. 2021;8:3800-8. doi:10.1002/ehf2.13559.
38. Sitnikova MYu, Lyasnikova EA, Yurchenko AV, et al. Results of 3 years work of the Russian hospital register of chronic heart failure (RUssian hoSpital Heart Failure Registry — RUS-HFR): relationship between management and outcomes in patients with chronic heart failure. Kardiologiia. 2018;58(10S):9-19. (In Russ.) doi: 10.18087/cardio.2483.
39. Arutiunov AG, Dragunov DO, Arutiunov GP. First Open Study of Syndrome of Acute Decompensation of Heart Failure and Concomitant Diseases In Russian Federation: Independent Registry ORAKUL. Kardiologiia. 2015;55(5):12-21. (In Russ.) doi:10.18565/cardio.2015.5.12-21.
40. Arutyunov AG, Dragunov DO, Arutyunov GP, et al. Prognostically significant clinical phenotypes of patients with circulatory decompensation in the Russian Federation. Russian Heart Failure Journal. 2015;16(5):270-8. (In Russ.)
41. Oshchepkova EV, Lazareva NV, Satlykova DF, Tereshchenko SN. The First Results of the Russian Register of Chronic Heart Failure. Kardiologiia. 2015;(5):22-8. (In Russ.) doi:10.18565/cardio.2015.5.22-28.
42. Lazareva NV, Oshchepkova EV, Orlovsky AA, Tereschenko SN. Clinical characteristics and quality assessment of the treatment of patients with chronic heart failure with diabetes mellitus. Terapevticheskii Arkhiv (Ter. Arkh.). 2020;92(4):37-44. (In Russ.) doi:10.26442/00403660.2020.04.000474.
43. Shutemova EA, Belova OA, Rachkova SA, Romanchuk SV. Clinical guidelines performance in patients with chronic heart failure: the data of 2015 registry in Ivanovo region. Cardio-IT. 2016;3(1):e0104. (In Russ.) doi:10.15275/cardioit.2016.0104.
44. Korotin AS, Kiselev AR. System of clinical indicators for patients with chronic heart failure. Cardio-IT. 2016;3(3): e0303. (In Russ.) doi:10.15275/cardioit.2016.0303.
45. Gridnev VI, Kiselev AR, Posnenkova OM, et al. Objectives and design of Russian Registry of Hypertension, Coronary Artery Disease, and Chronic Heart Failure. Russian Open Medical Journal. 2017;6:e0201. doi:10.15275/rusomj.2017.0201.
46. Loukianov MM, Kozminsky AN, Martsevich SYu, et al. Patients with Combination of Chronic Heart Failure, Hypertension and History of Myocardial Infarction: Clinical and Anamnestic Characteristics, Administration of ACE Inhibitors, Angiotensin Receptor Blockers, β-Blockers and Adherence to the Drug Therapy (Data of Outpatient Registry RECVASA). Rational Pharmacotherapy in Cardiology. 2017;13(2):207-12. (In Russ.) doi:10.20996/1819-6446-2017-13-2-207-212.
47. Zhirov IV, Safronova NV, Osmolovskaya YuF, Тereshchenko SN. Prognostic value of atrial fibrillation in patients with heart failure and different left ventricular ejection fraction: results of the multicenter RIF-CHF register. Russian Journal of Cardiology. 2021;26(1):4200. (In Russ.) doi:10.15829/1560-4071-2021-4200.
48. Reitblat OM, Airapetian AA, Lazareva NV, et al. Creation of registers as one of the mechanisms for improving medical care for patients with chronic heart failure. Problem state. Terapevticheskii Arkhiv. 2023;95(9):739-45. (In Russ.) doi:10.26442/00403660.2023.09.202370/.
49. Lazareva NV, Airapetian AA, Reitblat OM, et al. Features of drug therapy in patients with chronic heart failure in real clinical practice (chronic heart failure registry in the Tyumen region). Russian Cardiology Bulletin. 2024;19(4-1):72-9. (In Russ.) doi:10.17116/Cardiobulletin20241904172.
50. Endubaeva GV, Solovyova AE, Medvedev AE, et al. Compliance of the management of hospitalized patients with heart failure with the quality criteria for health care: data from the St. Petersburg registry. Russian Journal of Cardiology. 2023;28(4S):5621. (In Russ.) doi:10.15829/1560-4071-2023-5621. EDN: BBAIJN.
51. Soloveva AE, Medvedev AE, Lubkovsky AV, et al. Total, age- and sex-specific mortality after discharge of patients with heart failure: the first large-scale cohort real-world study on Russian population. Russian Journal of Cardiology. 2024;29(6):5940. (In Russ.) doi:10.15829/1560-4071-2024-5940. EDN: CTTQTF.
52. Soloveva AE, Endubaeva GV, Avdonina NG, et al. ICD-10 code-based definition of heart failure in Saint Petersburg electronic health records: prevalence, health care utilization and outcomes. Russian Journal of Cardiology. 2021;26(S3):4621. (In Russ.) doi:10.15829/1560-4071-2021-4621.
53. Shlyakhto EV, Belenkov YuN, Boytsov SI, et al. Prospective observational multicenter registry study of patients with heart failure in the Russian Federation (PRIORITET-CHF): rationale, objectives and design of the study. Russian Journal of Cardiology. 2023;28(6):5456. (In Russ.) doi:10.15829/1560-4071-2023-5456. EDN: LKSHVP.
54. Shlyakhto EV, Belenkov YuN, Boytsov SA, et al. Interim analysis of a prospective observational multicenter registry study of patients with chronic heart failure in the Russian Federation "PRIORITET-CHF": initial characteristics and treatment of the first included patients. Russian Journal of Cardiology. 2023;28(10):5593. (In Russ.) doi:10.15829/1560-4071-2023-5593. EDN: AMDHTV.
55. Zvartau NE, Villevalde SV, Konradi AO, et al. Management of health care for patients with heart failure in the Northwestern, North Caucasian, Volga and Southern Federal Districts of the Russian Federation: 6-year changes and future prospects. Russian Journal of Cardiology. 2025;30(3):6276. (In Russ.) doi:10.15829/1560-4071-2025-6276. EDN: ZHDPXF.
56. Posnenkova OM, Gridnev VI. Developing the system of quality measures for medical care assessment in patients with chronic heart failure: methodology and criteria (review). Saratov Journal of Medical Scientific Research. 2024;20(4):425-35. (In Russ.) doi:10.15275/ssmj425. EDN: JJDYNP.
Supplementary files
Review
For citations:
Posnenkova O.M., Bogdanova T.M., Fedonnikov A.S. Practical and methodological aspects of managing a registry to assess the quality of health care for patients with heart failure. A systematic review. Russian Journal of Cardiology. 2025;30(9S):6345. (In Russ.) https://doi.org/10.15829/1560-4071-2025-6345. EDN: UFGGKN







































